本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

135.30
-6.0750-4.30%
成交量:71.34万
成交额:9,759.95万
市值:138.00亿
市盈率:19.83
高:139.60
开:139.60
低:134.89
收:141.37
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:0.83
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.74
市盈率(LYR):28.97

数据加载中...

2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/05

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

重要事件披露

Form 8-K - Current report
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]